Left Ventricular Dysfunction Switches Mesenchymal Stromal Cells Toward an Inflammatory Phenotype and Impairs Their Reparative Properties Via Toll-Like Receptor-4Clinical Perspective

  • Nili Naftali-Shani, La-Paz Levin-Kotler, Dahlia Palevski, Uri Amit, David Kain, Natalie Landa, Edith Hochhauser, Jonathan Leor
  • Circulation, March 2017, Wolters Kluwer Health
  • DOI: 10.1161/circulationaha.116.023527

Targeting Toll-like Receptor-4 could improve safety and efficacy of cell therapy

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1161/circulationaha.116.023527

The following have contributed to this page: Dr Nili Naftali-Shani